Tag: Zepbound
-
Overcoming Nausea: The Next Wave of Weight-Loss Drugs and Safer Experiences
Search for a ‘painless’ path to weight loss Millions of Americans have found success with prescription medications like Wegovy and Zepbound, which help reduce appetite and boost weight loss. Yet the journey isn’t the same for everyone. A common obstacle is nausea, a side effect that can range from mild discomfort to significant disruption in…
-
Brain scientists pursue nausea-free weight-loss drugs amid GLP-1 breakthroughs
Overview: The quest for nausea-free weight-loss medications Millions of Americans have achieved impressive weight loss with medications such as Wegovy and Zepbound, which target the body’s GLP-1 pathways to curb appetite and boost metabolic effects. Yet the journey with these drugs isn’t without rough edges. Nausea, vomiting, and other gastrointestinal side effects remain common early…
-
Brain scientists pursue nausea-free weight-loss drugs to improve outcomes
Overview: The quest for nausea-free weight-loss drugs Across the United States and beyond, millions have found success shedding pounds with medications such as Wegovy and Zepbound. These GLP-1 receptor agonists help reduce appetite and slow digestion, leading to meaningful weight loss for many individuals. Yet the journey isn’t without its rough edges. A sizable share…
-
Brain recordings reveal short-lived effects of tirzepatide on food cravings
New clues on how tirzepatide affects cravings Researchers are shedding light on how tirzepatide, a drug sold as Mounjaro and Zepbound for obesity and related conditions, influences the brain’s response to food. In a rare look at brain activity during treatment, scientists observed transient shifts in the neural circuits that underlie appetite and reward. The…
-
Brain Recordings Show Short-Lived Impact of Tirzepatide on Food Cravings
New insights into tirzepatide’s neural effects In a rare peek inside the brains of people with obesity and loss of control eating, researchers used brain recordings to study how tirzepatide—a drug sold as Mounjaro and Zepbound—affects cravings. The findings, though preliminary, suggest that the medication can acutely suppress activity in brain regions tied to reward…